Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 3 8Phase 4 5Phase 1 5Phase NA 2Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2

Status

Completed 17Terminated 5Unknown 4Withdrawn 3Recruiting 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 4Neoplasm Metastasis 2Breast Neoplasm Malignant Female 1

Interventions

Saline Solution 6Fentanyl 6Sodium Chloride 5Letrozole 5Dexamethasone 5Pregabalin 4Ketamine 4Goserelin 4Gemcitabine 4Bevacizumab 4Tranexamic Acid 3Photochemotherapy 3Pemetrexed 3Paclitaxel 3Metformin 3Leuprolide 3Docetaxel 3Cyclophosphamide 3Carboplatin 3Capecitabine 3Acetaminophen 3ulipristal acetate 2sodium glycididazole 2nilotinib 2liposomal doxorubicin 2human papillomavirus vaccine, L1 type 16, 18 2flurbiprofen axetil 2fludarabine 2fluciclovine F-18 2epoetin beta 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Letrozole × Clear all
NCT04289805 2025-01-31

fAMHOPE

Erasme University Hospital

Phase 4 Terminated
96 enrolled
Breast

Breast Neoplasm Malignant Female

NCT03220178 2022-01-06

PRECYCLE

Palleos Healthcare GmbH

Phase 4 Terminated
532 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00375752 2017-06-26

FEMZONE

Novartis

Phase 4 Terminated
168 enrolled 11 charts
Breast

Breast Neoplasms

NCT00241046 2012-04-19

Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment

Novartis

Phase 4 Terminated
13 enrolled
Breast

Breast Neoplasms

NCT00171847 2010-03-31

eLEcTRA

Novartis

Phase 4 Terminated
93 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡